The Pharmacist September/October 2018 - Page 3

VIEWSEDITORIAL Can pharmacy bounce back after these momentous challenges? ‘ C hange or die,’ goes the old adage. Community pharmacy has repeatedly proved that it is nothing if not adaptable. From the apothecaries of old who would whip up remedies from natural ingredients and the old-fashioned chemists who put together tinctures, to the more clinical, service-based pharmacists of today, the sector’s enduring success has arguably stemmed from its willingness to roll with the punches. The next few months promise to test this adaptability. First comes the implementation of the Falsified Medicines Directive (FMD) in February. The pan-European anti-counterfeiting measures will see pharmacists scan all packs of medication to verify their authenticity, which is likely to put further pressure on already overstretched pharmacy teams. If this wasn’t enough, Britain will finally begin formal preparations to leave the European Union in March after two-and-a-half interminable years of dithering about what exit deal we a) want and b) can feasibly negotiate. Whatever your views on Brexit, the current uncertainty around negotiations is likely to have repercussions on medicines stocks and prices for years to come, as our reporter Léa Legraien found (see page 12). With two such momentous challenges on the horizon, the sector is in need of strong leadership – particularly as this is arguably Pharmacists are lacking in the UK’s political adaptable and landscape at present. The new chief executive of the Pharmaceutical the next few months Services Negotiating Committee will test this (PSNC) Simon Dukes has kicked off his tenure with fighting talk, promising to push for a more modern service-based contract. Turn to page 18 for my interview with him. With negotiations between PSNC and the Government yet to commence, let’s hope those talks prove smoother and more beneficial than the ones between the EU and the UK. But whatever the outcome, I feel confident that pharmacy’s Teflon-like resilience will stand it in good stead. Come on, pharmacy – you’ve got this. Beth Kennedy Editor-in-chief The Pharmacist Address The Pharmacist, Cogora, 140 London Wall, London EC2Y 5DN Email bethkennedy@cogora. com Twitter @Pharmacist_News Group editor Gemma Collins Editor-in-chief Beth Kennedy Reporter Léa Legraien Art editor James Depree Commercial director Jamie Driver 020 7214 0620 Editorial advisers Ash Soni, LPN chair Pharmacy (London) Nick Hunter, chief officer, Nottinghamshire LPC Deborah Evans, managing director, Pharmacy Complete Paul Mayberry, owner, Mayberry Pharmacy Group Jay Badenhorst, superintendent, Whitworth Chemists Leyla Hannbeck, chief pharmacist, National Pharmacy Association Delivery and subscription Subscription rates: UK Personal £60, Institutions £120; back issues/single copies (each) £20. Outside UK Personal £75, Institutions £150; back issues/single copies (each) £20. Published in the UK by Cogora Limited. Printed in the UK by Alban House Print Services Ltd, London. Copyright © Cogora Limited 2018. The contents of this publication are protected by copyright. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means without prior written permission of Cogora Limited. The views expressed in this publication are not necessarily those of the Publisher, any of its employees or agents, or of the Editorial Board. While the aforementioned parties have taken every care with regard to the accuracy of all editorial and advertisement material, they cannot be held responsible for any errors or omissions contained therein. September/October 2018 | The Pharmacist | 3